Wolverine Trading
HRTX icon

Wolverine Trading’s Heron Therapeutics HRTX Stock Holding History

Wolverine Trading’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,330
Closed -$18.6K – 5202
2024
Q4 		$18.6K Buy
12,330
+865
+8% +$1.4K ﹤0.01% 5115
2024
Q3 		$22.8K Buy
+11,465
New +$27.4K ﹤0.01% 4621
2024
Q2 		– Sell
-15,553
Closed -$47.8K – 4799
2024
Q1 		$43.1K Sell
15,553
-1,168
-7% -$2.94K ﹤0.01% 4241
2023
Q4 		$28.4K Buy
+16,721
New +$18.4K ﹤0.01% 4345
2021
Q2 		– Sell
-23,128
Closed -$368K – 6302
2021
Q1 		$354K Buy
+23,128
New +$412K ﹤0.01% 4235
2020
Q3 		– Sell
-15,494
Closed -$221K – 4790
2020
Q2 		$221K Buy
+15,494
New +$255K ﹤0.01% 3713
2020
Q1 		– Sell
-16,727
Closed -$314K – 4890
2019
Q4 		$395K Buy
16,727
+1,050
+7% +$23.2K ﹤0.01% 3293
2019
Q3 		$307K Sell
15,677
-20,743
-57% -$382K ﹤0.01% 3142
2019
Q2 		$677K Sell
36,420
-7,007
-16% -$140K ﹤0.01% 2405
2019
Q1 		$1.06M Buy
43,427
+21,017
+94% +$550K ﹤0.01% 2019
2018
Q4 		$532K Buy
22,410
+13,996
+166% +$385K ﹤0.01% 2568
2018
Q3 		$266K Sell
8,414
-35,736
-81% -$1.33M ﹤0.01% 3895
2018
Q2 		$1.22M Hold
44,150
– – ﹤0.01% 2052
2018
Q1 		$1.22M Buy
+44,150
New +$1M ﹤0.01% 2052

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's HRTX Position: Q1 2025 in Review

Wolverine Trading sold out of Heron Therapeutics (HRTX) in Q1 2025, closing a stake of 12,330 shares — an estimated $18.6K sold.

Wolverine Trading first reported a position in HRTX in Q1 2018 and held it in 14 quarters. The position peaked at $1.22M in Q2 2018. 164 funds tracked by Wall St. Rank hold HRTX as of Q1 2025.

  • Wolverine Trading reported no remaining Heron Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Wolverine Trading sold 12,330 Heron Therapeutics shares in Q1 2025, an estimated $18.6K.
  • Wolverine Trading first reported a position in Heron Therapeutics in Q1 2018 and held it in 14 quarters.
  • Wolverine Trading's Heron Therapeutics position peaked at $1.22M in Q2 2018.
  • 164 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.